This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canica, M. M.
Right arrow Articles by Paul, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canica, M. M.
Right arrow Articles by Paul, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Feb 1997, 374-378, Vol 41, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases

MM Canica, M Barthelemy, L Gilly, R Labia, R Krishnamoorthy and G Paul
INSERM U 120, Hopital Robert Debre, Paris, France.

IRT-14 (TEM-45) is a new mutant TEM-type beta-lactamase that was isolated from clinical Escherichia coli P37 and that confers resistance to broad-spectrum penicillins with reduced sensitivity to beta- lactamase inhibitors. The MICs of amoxicillin alone and of amoxicillin combined with 2 micrograms of clavulanic acid or 2 micrograms of tazobactam per ml were 4,096, 2,048, and 1,024 micrograms/ml, respectively. The strain was susceptible to cephalosporins, aztreonam, moxalactam, and imipenem. The enzyme was purified to homogeneity, and values of the kinetic parameters Kcat, Km, and Kcat/Km were determined for different substrates. This enzyme, with a pI of 5.2, was found to have reduced affinity for broad-spectrum penicillins and cephalosporins. The values of 50% inhibitory concentrations of clavulanic acid, sulbactam, tazobactam, and brobactam are correlated with the higher KmS for substrates. The resistance of E. coli P37 to mechanism-based inactivators results from a higher level of production of the TEM-derived enzyme due to the G-to-T substitution at position 162 (G-162-->T) in the promoter region of blaTEM and from the structural modifications resulting from the Met-69-->Leu and Arg-275-- >Gln substitutions that characterize IRT-14 beta-lactamase.


This article has been cited by other articles:

  • Mendonca, N., Leitao, J., Manageiro, V., Ferreira, E., the Antimicrobial Resistance Surveillance Program, , Canica, M. (2007). Spread of Extended-Spectrum {beta}-Lactamase CTX-M-Producing Escherichia coli Clinical Isolates in Community and Nosocomial Environments in Portugal. Antimicrob. Agents Chemother. 51: 1946-1955 [Abstract] [Full Text]  
  • Jones, D. D. (2005). Triplet nucleotide removal at random positions in a target gene: the tolerance of TEM-1 {beta}-lactamase to an amino acid deletion. Nucleic Acids Res 33: e80-e80 [Abstract] [Full Text]  
  • Pagan-Rodriguez, D., Zhou, X., Simmons, R., Bethel, C. R., Hujer, A. M., Helfand, M. S., Jin, Z., Guo, B., Anderson, V. E., Ng, L. M., Bonomo, R. A. (2004). Tazobactam Inactivation of SHV-1 and the Inhibitor-resistant Ser130 -> Gly SHV-1 {beta}-Lactamase: INSIGHTS INTO THE MECHANISM OF INHIBITION. J. Biol. Chem. 279: 19494-19501 [Abstract] [Full Text]  
  • Kaye, K. S., Gold, H. S., Schwaber, M. J., Venkataraman, L., Qi, Y., De Girolami, P. C., Samore, M. H., Anderson, G., Rasheed, J. K., Tenover, F. C. (2004). Variety of {beta}-Lactamases Produced by Amoxicillin-Clavulanate-Resistant Escherichia coli Isolated in the Northeastern United States. Antimicrob. Agents Chemother. 48: 1520-1525 [Abstract] [Full Text]  
  • Schroeder, W. A., Locke, T. R., Jensen, S. E. (2002). Resistance to {beta}-Lactamase Inhibitor Protein Does Not Parallel Resistance to Clavulanic Acid in TEM {beta}-Lactamase Mutants. Antimicrob. Agents Chemother. 46: 3568-3573 [Abstract] [Full Text]  
  • Alonso, R., Gerbaud, G., Galimand, M., Courvalin, P. (2002). TEM-103/IRT-28 {beta}-Lactamase, a New TEM Variant Produced by Escherichia coli BM4511. Antimicrob. Agents Chemother. 46: 3627-3629 [Abstract] [Full Text]  
  • Arpin, C., Labia, R., Dubois, V., Noury, P., Souquet, M., Quentin, C. (2002). TEM-80, a Novel Inhibitor-Resistant {beta}-Lactamase in a Clinical Isolate of Enterobacter cloacae. Antimicrob. Agents Chemother. 46: 1183-1189 [Abstract] [Full Text]  
  • Vakulenko, S., Golemi, D. (2002). Mutant TEM {beta}-Lactamase Producing Resistance to Ceftazidime, Ampicillins, and {beta}-Lactamase Inhibitors. Antimicrob. Agents Chemother. 46: 646-653 [Abstract] [Full Text]  
  • Leflon-Guibout, V., Heym, B., Nicolas-Chanoine, M.-H. (2000). Updated Sequence Information and Proposed Nomenclature for blaTEM Genes and Their Promoters. Antimicrob. Agents Chemother. 44: 3232-3234 [Abstract] [Full Text]  
  • Leflon-Guibout, V., Speldooren, V., Heym, B., Nicolas-Chanoine, M.-H. (2000). Epidemiological Survey of Amoxicillin-Clavulanate Resistance and Corresponding Molecular Mechanisms in Escherichia coli Isolates in France: New Genetic Features of blaTEM Genes. Antimicrob. Agents Chemother. 44: 2709-2714 [Abstract] [Full Text]  
  • Fiett, J., Stankiewicz, M., Przondo-Mordarska, H., Hryniewicz, W., Gniadkowski, M. (2000). A Novel Complex Mutant beta -Lactamase, TEM-68, Identified in a Klebsiella pneumoniae Isolate from an Outbreak of Extended-Spectrum beta -Lactamase-Producing Klebsiellae. Antimicrob. Agents Chemother. 44: 1499-1505 [Abstract] [Full Text]  
  • Laurent, F., Poirel, L., Naas, T., Chaibi, E. B., Labia, R., Boiron, P., Nordmann, P. (1999). Biochemical-Genetic Analysis and Distribution of FAR-1, a Class A beta -Lactamase from Nocardia farcinica. Antimicrob. Agents Chemother. 43: 1644-1650 [Abstract] [Full Text]  
  • Bermudes, H., Jude, F., Chaibi, E. B., Arpin, C., Bebear, C., Labia, R., Quentin, C. (1999). Molecular Characterization of TEM-59 (IRT-17), a Novel Inhibitor-Resistant TEM-Derived beta -Lactamase in a Clinical Isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 43: 1657-1661 [Abstract] [Full Text]  
  • Chaibi, E. B., Sirot, D., Paul, G., Labia, R. (1999). Inhibitor-resistant TEM {beta}-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother 43: 447-458 [Abstract] [Full Text]  
  • Giakkoupi, P., Tzelepi, E., Legakis, N. J., Tzouvelekis, L. S. (1999). Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 {beta}-lactamases. J Antimicrob Chemother 43: 23-29 [Abstract] [Full Text]  
  • Caniça, M. M., Caroff, N., Barthélémy, M., Labia, R., Krishnamoorthy, R., Paul, G., Dupret, J.-M. (1998). Phenotypic Study of Resistance of beta -Lactamase-Inhibitor-Resistant TEM Enzymes Which Differ by Naturally Occurring Variations and by Site-Directed Substitution at Asp276. Antimicrob. Agents Chemother. 42: 1323-1328 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»